V1 and V2 Domains of HIV Envelope Contribute to CCR5 Antagonist Resistance

Journal of Virology
Ellen WuLee Ratner

Abstract

Vicriviroc (VCV) is a CCR5 antagonist that blocks the viral entry of CCR5-tropic (R5) virions by binding to and inducing a conformational change in the chemokine receptor. Clinical resistance to CCR5 antagonists occurs in two phases, competitive and noncompetitive stages. In this study, we analyzed two subjects, from a phase 2b VCV clinical trial, whose quasispecies contained R5 and dual-mixed virions at the earliest recorded time of virological failure (VF). Genotypic analysis of R5-tropic patient-derived envelope genes revealed significant changes in the V1/V2 coding domain and convergence toward a more homogenous sequence under VCV therapy. Additionally, a small population of baseline clones sharing similar V1/V2 and V3 domains with the predominant VF isolate was observed. These clones were denoted preresistant based on their genotype. Preresistant clones and chimeric clones containing V1/V2 regions isolated during VF displayed high 50% inhibitory concentration (IC50) values relative to those at baseline, consistent with early competitive resistance. Genotypic analysis of the dual-tropic clones also showed significant changes in the V1/V2 region, different from the resistant R5-tropic viruses. Our findings suggest that the V...Continue Reading

References

Dec 1, 1996·Computer Applications in the Biosciences : CABIOS·N GaltierC Gautier
Jan 10, 2002·Proceedings of the National Academy of Sciences of the United States of America·Alexandra TrkolaJohn P Moore
Mar 23, 2004·Nucleic Acids Research·Robert C Edgar
Feb 24, 2005·AIDS Research and Human Retroviruses·Oliver HartleyJohn P Moore
Apr 3, 2007·PLoS Computational Biology·Oliver SanderFrancisco S Domingues
Jun 16, 2007·The Journal of Infectious Diseases·Roy M GulickUNKNOWN AIDS Clinical Trials Group 5211 Team
Dec 11, 2007·Nature Biotechnology·Thomas LengauerRolf Kaiser
Apr 3, 2009·Current Opinion in HIV and AIDS·Donald E Mosier
Sep 22, 2010·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Timothy J HenrichDaniel R Kuritzkes
May 16, 2012·Cellular Microbiology·Per Johan Klasse
May 29, 2015·Journal of Virology·Ruimin PanXiang-Peng Kong
Oct 30, 2016·Expert Opinion on Investigational Drugs·Michelle B KimLawrence J Wilson

❮ Previous
Next ❯

Citations

Jul 9, 2020·SAGE Open Medicine·Linh Vu Phuong DangLinus Olson
Dec 17, 2020·International Journal of Molecular Sciences·Ignacio Relaño-Rodríguez, Maria Ángeles Muñoz-Fernández

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.